July 07, 2026 09:19 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
China tests ballistic missile from nuclear submarine in Pacific: Australia, New Zealand respond | Baruipur horror: Main accused in alleged rape and murder of minor girl arrested; senior cops dissatisfied with handling of the case | Defence stocks jump after Rs 52,000 crore DAC approval sparks buying frenzy | 'Harry Kane is a great player': Donald Trump after England knocked Mexico out of the World Cup | 'Referee gave a lot against us': Harry Kane reacts after England's dramatic win over Mexico | England hold nerve with 10 men to knock out Mexico in five-goal World Cup classic | 'Why can't citizens protest against the government? They are being made slaves by slapping cases': Bombay HC slams Mumbai Police, quashes activist's externment | 'First he cheats on me...': Siya Goyal's old pub video goes viral amid probe into fiancé Ketan Agarwal's alleged murder | Ronaldo's goal, Ramos' last-gasp winner send Portugal past Croatia, set up Spain clash | India-US trade deal almost done! Piyush Goyal hints at breakthrough

India records over 24,000 COVID-19 cases in last 24 hrs

| @indiablooms | Jul 05, 2020, at 10:45 am

New Delhi/IBNS: Setting a new record, India registered  24,850 fresh COVID-19 cases in the last 24 hours, taking the country's tally to 6,73,165, the Union Health Ministry stated on Sunday.

India witnessed 613 deaths during the period, taking the total number of fatalities to 19,268.

The active cases in the country have mounted up to 2,44,814 while 4,09,083 people have been discharged or have recovered so far.

Meanwhile, the Indian Council of Medical Research (ICMR) in partnership with  Bharat Biotech has announced to launch a vaccine to combat COVID-19 by Aug 15.

'COVAXIN' will undergo clinical trials after the Drug Controller General of India - CDSCO, Ministry of Health & Family Welfare, has granted permission to start phase I and phase II of human trials following the company's preclinical studies, demonstrating safety and immune response.

 

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.